Public tender Open

Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tocilizumab (ATC-Code nach WHO: L04AC07)

See the full notice and documents: start the free trial

14 day free trial. No card needed.

Buyer
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
Country
Germany
Deadline
Jul 31, 2028
Sector
Healthcare & medical
CPV code
33600000 Pharmaceutical products
Published
Oct 28, 2026

The full description, the documents, the buyer’s contacts and the link to the official portal open with the free trial.

More tenders in Germany

Similar open tenders

  1. Open-house discount agreements 2026-11 - Dorzolamide ATR (EDO)
    Techniker Krankenkasse Deadline: Oct 31, 2026
  2. Open House Original Discount Contracts 2025-08 - Roxadustat
    Techniker Krankenkasse Deadline: Oct 31, 2026
  3. Open House Discount Contracts 2025-14 - Guanfacine (RET, strengths: 1-4 mg)
    Techniker Krankenkasse HEK - Hanseatische Krankenkasse Handelskrankenkasse (hkk) Deadline: Oct 31, 2026
  4. Open House Biologics Discount Contracts 2025-24 - Ranibizumab
    Techniker Krankenkasse Handelskrankenkasse (hkk) Deadline: Oct 31, 2026
  5. Open House Biologics Discount Contracts 2025-27 - Tocilizumab
    Techniker Krankenkasse HEK - Hanseatische Krankenkasse Handelskrankenkasse (hkk) Kaufmännische Krankenkasse (KKH) Deadline: Oct 31, 2026
  6. Conclusion of non-exclusive pharmaceutical discount agreements pursuant to § 130a para. 8 SGB V by way of an open-house model for the active substance tacrolimus (WHO ATC code: L04AD02)
    AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen Deadline: Oct 31, 2026
  7. Conclusion of a non-exclusive pharmaceutical discount agreement pursuant to § 130a para. 8 SGB V by way of an open-house model for the active substance certolizumab pegol (WHO ATC code: L04AB05)
    AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen Deadline: Oct 31, 2026
  8. Conclusion of non-exclusive pharmaceutical discount agreements pursuant to § 130a para. 8 SGB V by way of an open-house model for the active substance glyceryl trinitrate (WHO ATC code: C05AE01)
    AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen Deadline: Oct 31, 2026